Tetravet

Quick links to important sections

Tetravet

Method of action: Ophthalmologicals

Treatment option: Blepharitis, Keratitis, Trachoma

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tetravet

Tetravet is a foundational veterinary medicine defined by its specific chemical composition and its classification as a broad-spectrum antibiotic. It functions as a systemic anti-infective agent and is available strictly by prescription for use in animals.


Quick Facts about Tetravet

Property Description
Active ingredient Oxytetracycline Hydrochloride
Form Injectable solution, Powder for oral solution
Pharmacological class Tetracycline group antibiotic
Common use Management of bacterial infections
Origin Semi-synthetic

What Type of Medicine is Tetravet?

Tetravet is classified as a broad-spectrum antibiotic belonging to the Tetracycline group of anti-infective agents, used exclusively in veterinary medicine. Its active component, Oxytetracycline, is clinically recognized for its reliable efficacy against a diverse array of both Gram-positive and Gram-negative bacteria, setting it apart as a highly versatile treatment option.


Composition, Origin, and Available Forms

The core substance in the medicine is Oxytetracycline Hydrochloride, which serves as the single active ingredient. This compound is semi-synthetic, meaning the parent drug is derived naturally from the organism Streptomyces rimosus and then chemically formulated into the Hydrochloride salt to enhance stability for medicinal application. For administration, the product is commonly supplied as an injectable solution for parenteral routes and as a powder for oral solution suitable for delivery through drinking water or feed.


What is the General Purpose of Oxytetracycline?

The general purpose of the active component is to function as a bacteriostatic agent to manage and contain the spread of bacterial infections. By interfering with the pathogens' ability to synthesize essential proteins, it effectively halts their growth and multiplication. This primary function—the inhibition of bacterial protein synthesis—contains the infection, facilitating the animal's natural immune system response to clear the remaining pathogens and promote recovery.

Regulatory References

  1. EMA veterinary medicinal products information

What side effects are possible with Tetravet?

Possible Side Effects and Safety Information

The safety profile for Tetravet (Oxytetracycline Hydrochloride) is established through official regulatory documents, classifying potential adverse reactions by frequency and physiological system. All documented effects are based on reporting in clinical use and are organized according to standard regulatory frameworks.


Documented Adverse Reactions

Adverse reactions are officially categorized, with some being listed as Rare (affecting 1 to 10 per 10,000 animals treated), including Hypersensitivity reactions, Hepatic toxicosis (liver toxicity), and Haematologic effects. Very Rare reactions (less than 1 per 10,000) include local site effects such as injection site swelling, yellow discoloration, or necrosis.

Reactions are grouped by System-Organ Class (SOC), noting potential effects on the Gastrointestinal System (e.g., diarrhea, vomiting), the Nervous System (e.g., restlessness, ataxia, trembling), and the Skin (e.g., Photosensitivity).

Serious Safety Considerations and Limitations

Regulatory documents highlight several serious adverse reactions, including the risk of Anaphylaxis (a severe allergic reaction) and Cardiovascular Collapse. The medicine is explicitly Contraindicated in animals with a known hypersensitivity to the tetracycline class and in those with severely impaired renal and/or liver function.


Specific Safety Notes

Young Animals are subject to special safety notes, as administration during tooth and bone development may lead to yellow, brown, or grey discoloration of teeth and bones. Additionally, regulatory labels advise against using this medication simultaneously with preparations containing Calcium, Magnesium, or Aluminium salts, due to the risk of reduced systemic absorption. Transient local reactions at the injection site are a common finding that typically resolve within a few days.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory documents confirm that Oxytetracycline Hydrochloride generally possesses a wide safety margin, although toxic symptoms can be documented, especially when specific factors are present. The risk of toxicity is increased in animals with seriously impaired renal and/or liver function, or following rapid intravenous administration.

Documented Overdose Presentations

The officially documented clinical manifestations include central nervous system signs such as restlessness, ataxia, and trembling. Systemic effects can involve respiratory abnormalities (labored breathing) and severe outcomes like generalized collapse, hypotension, and cardiovascular collapse. Fatal diarrhea is also a documented risk in specific susceptible species. Localized reactions, such as swelling at injection or soft-tissue sites, are also listed.

Required Emergency Actions

The official regulatory guidance mandates an immediate response: the product must be discontinued immediately upon the first sign of an adverse reaction or suspected overdose. The user is required to seek the advice of your veterinarian without delay. Management is constrained by the official statement that there is no known specific antidote, necessitating that treatment be limited to providing symptomatic and supportive care. This management protocol is strictly defined by regulatory guidelines.

Therapeutic Uses of Tetravet

What Tetravet Treats: Main Uses and Benefits

The medication is used across several therapeutic domains in livestock. It is commonly used in clinical settings that involve acute or unstable symptom patterns, providing broad anti-infective support.

Tetravet is applied across domains where additional symptomatic support is needed to address systemic and localized bacterial infections. It is relevant in conditions characterized by periods of heightened symptoms, including serious respiratory conditions like pneumonia and shipping fever complex, gastrointestinal distress such as infectious diarrhea, and localized infections like foot rot, mastitis, and metritis. It is applied in scenarios where additional management of discomfort is required, especially during phases of increased distress or discomfort. The medication helps address symptom clusters that may become intense or disruptive, such as fever, coughing, lameness, and swelling. This supportive use may assist the animal in coping more steadily with symptom fluctuations and helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Support for Symptomatic Discomfort

Symptom Domain Conditions Managed (Examples) Benefit Provided
Systemic Imbalance Pneumonia, Shipping Fever, Calf Scours Contributes to improved comfort and helps ease overall symptom burden.
Localized Discomfort Foot Rot, Joint Ill, Mastitis Supports coping with difficult episodes, and may assist in easing the symptomatic burden related to swelling and pain.

Regulatory References

  1. FDA Animal Drugs @ FDA Summary

Eligibility and Restrictions for Use

Tetravet (Tetracycline) is an antibiotic prescribed for a variety of bacterial infections, including respiratory tract, skin, eye, urinary, and certain sexually transmitted infections. It is also used in conditions such as severe acne and rosacea.


Who Can Use Tetravet?

Tetravet is generally considered for use in adults and children aged 8 years and older when prescribed for a susceptible bacterial infection. The decision for use is always based on a thorough medical assessment of the individual's condition and history.


When Tetravet Should Not Be Used (Contraindications)

Tetravet is not safe for everyone and is generally contraindicated in the following groups due to the risk of serious side effects:

Condition Reason for Contraindication
Allergy to Tetracyclines History of hypersensitivity (allergic reaction) to tetracycline or related antibiotics.
Children Under 8 Years Old Risk of permanent tooth discoloration (yellow/gray) and enamel hypoplasia, and potential effects on bone growth.
Pregnancy Risk of tooth discoloration and inhibited skeletal development in the fetus, and potential liver issues for the mother.
Breastfeeding The drug passes into breast milk and may affect bone and teeth development in the nursing infant.

Caution is also advised for patients with pre-existing kidney or liver disease, as dosage adjustments may be necessary to prevent accumulation of the drug and potential toxicity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Tetravet (oxytetracycline) is predominantly defined by its ability to chelate, or bind, to certain ions, which can significantly affect its absorption and the efficacy of co-administered treatments. Regulatory documents specify constraints related to both pharmacokinetic and pharmacodynamic mechanisms.


Documented Interaction Categories

Category Practical Constraint & Effect
Cation-Containing Products (e.g., Antacids, Iron Supplements, Calcium Salts, Bismuth) Co-administration leads to a decreased serum concentration of Tetravet. Timing separation (e.g., 2–3 hours) is required for antacids. Co-use with calcium salt solutions is restricted.
Other Antibiotics (e.g., Penicillins) Co-use can lead to decreased efficacy of the interacting antibiotic. This represents a pharmacodynamic interference.

Official Regulatory Summary

Interactions with products containing aluminium, magnesium, zinc, calcium, and iron are the primary focus of the regulatory profile. These substances decrease the absorption of Tetravet, requiring a mandatory 2- to 3-hour separation in administration when taken with antacids. Specific medicinal products, including Iron dextran and Penicillin, are noted to have their efficacy decreased when co-administered. The official documentation strictly prohibits simultaneous use with certain products, such as calcium salt solutions, to prevent inadequate drug exposure.

Mechanism of Action

How Tetravet Works


Selective Inhibition of Bacterial Protein Synthesis

This mechanism centers on the drug's highly specific and reversible binding to the 30S ribosomal subunit of the prokaryotic cell, specifically blocking the A-site. This molecular interference prevents the essential aminoacyl-tRNA from docking, which immediately halts the elongation of the polypeptide chain. This action arrests the creation of structural and enzymatic proteins required for cell division and metabolic maintenance.


Functional Bacteriostasis and Microbial Containment

The molecular blockade results in a functional effect known as bacteriostasis, meaning the drug forces the pathogenic population into a state of suspended growth and replication. This functional containment limits the microbial load and systemic dissemination of the infection. The physiological consequence of this is a containment of the microbial population, which facilitates the host's native immune system clearance of the non-replicating pathogens.


️ Limitations by Efflux and Chelation Dynamics

The efficacy of this mechanism can be physiologically constrained by bacterial resistance strategies, primarily the deployment of efflux pumps that actively transport the drug out of the cell, preventing it from reaching the ribosomal target. Chemically, the drug's action is also limited by its tendency to form inactive chelates with multivalent cations like Ca^2+ or Fe^3+, which reduces the amount of free, active drug available for absorption and subsequent ribosomal binding.

Dosage and Administration Information

Official Administration Guidelines for Tetravet

The following guidelines for the use of Tetravet, an oxytetracycline-based veterinary medication, are provided for informational purposes regarding administration. The proper route, dose, and frequency are essential for effective use and must be strictly followed.

Administration Scope Detail
Route of Administration Parenteral (IM, IV, SC, IP) for injectable forms; Oral for water-soluble powders (WSP) and boluses; Topical for spray; Intravaginal for boluses in reproductive diseases.
Dosing Schedule Varies significantly by formulation and species, calculated based on body weight (e.g., 2 ml / 10 kg body weight for 50 mg/ml injection; 1 g / 10 kg for some WSP forms in livestock).
Frequency and Timing Typically once daily for 3–5 days (injections) or 3–7 days (WSP). Long-Acting (LA) injectable forms are generally administered as a single dose. Oral forms mixed with water/feed are administered based on the animal's drinking/feeding schedule.
Preparation Requirements Water-soluble powders must be mixed with the animal's drinking water or feed; the solution must be prepared fresh daily. Injectable solutions are generally ready for use.
Missed-Dose Rules Not explicitly documented in procedural sections. The established protocol suggests maintaining a daily dose for the specified duration.

Procedural and Context Constraints

Special Conditions: The long-acting injection (Tetravet-LA) requires a single-site, single-dose administration; re-treatment may be necessary after 3–5 days for severe cases. A critical procedural restriction is that the use of Tetravet must not occur concurrently with solutions containing calcium salts, which can significantly decrease absorption. Use of oral powder forms in food-producing animals is subject to mandated withdrawal times before slaughter. The administration process is strictly dependent on the animal's weight, ensuring the correct milligram-per-kilogram dosage is delivered for the required number of treatment days.

Recent Clinical Evidence

The research record for Tetravet (Oxytetracycline) in veterinary medicine primarily consists of Clinical Efficacy Trials and modern Bioequivalence Studies. These studies were conducted to explore the medicine's role in three main areas: contexts related to Respiratory Diseases (like BRD and pneumonia), Bacterial Enteritis (scours), and Localized Infections (such as foot rot).

In trials for respiratory and localized conditions, researchers primarily measured outcomes related to systemic imbalance and the evolution of clinical signs over the short-term treatment period in animals like Beef Cattle and Swine. For enteritis, the focus was often on short-term management and patterns observed regarding the changes in visible symptoms. These findings informed the original regulatory conclusions for the drug's approved uses.

The evidence base, however, shows several limitations. The studies largely rely on older trial designs, and there is a recognized lack of data providing robust information on long-term durability or the effects over extended time intervals. Follow-up durations were limited in many pivotal efficacy studies. Furthermore, comparative evidence against the newest therapeutic options is scarce, and the prevalence of Antimicrobial Resistance (AMR) shows high heterogeneity across research, meaning that the clinical relevance of findings is uncertain due to localized resistance patterns.

Key Studies & References

  1. FDA Animal Drugs @ FDA Summary: NADA 016-563, Oxytetracycline Injection (Supporting Indications)

Frequently Asked Questions (FAQ)

Common questions about Tetravet (FAQ)


Q: How quickly should a person expect to feel the effects of Tetravet?

Official documentation for the active ingredient, Oxytetracycline, notes that improvement in clinical signs for susceptible infections is typically observed within 24 to 48 hours following the start of treatment. While this timeline is often mentioned in studies, individual responses can vary depending on the nature of the condition being treated.


Q: Can Tetravet cause long-term side effects or only temporary ones?

Most commonly reported adverse reactions, such as gastrointestinal issues, are typically temporary and resolve after treatment ends. However, regulatory information notes specific rare or serious effects, such as permanent tooth discoloration in young children, which are recognized as potential concerns regarding long-term effects. The potential for temporary, but serious, conditions like intracranial hypertension is also noted.


Q: How long does Tetravet typically stay in the body after the last dose?

The elimination time for the active component of Tetravet varies widely depending on the specific formulation used and individual factors. Pharmacokinetic studies show a gradual clearance from the body, with elimination occurring over several days following the last dose.


Q: What if I miss a dose of Tetravet—what does the official guidance say?

Standard guidance for this class of medicine describes that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the standard practice is to skip the missed dose and return to the regular schedule, which helps prevent a potentially excessive amount being taken too close together.


Q: Can Tetravet be safely combined with common pain relievers like ibuprofen?

Regulatory data on drug interactions has not explicitly listed a major interaction between Tetravet's active component and common non-steroidal pain relievers like ibuprofen. However, some sources suggest that ibuprofen may affect how the active ingredient is processed by the body. Information regarding all drug combinations is detailed within the official regulatory documentation.


Q: Why are people often told to complete the full course of Tetravet?

Official patient information describes the completion of the full course of therapy as necessary to ensure the complete containment of the infection. Not completing the full course may decrease the overall effectiveness of the treatment, even if symptoms appear to improve quickly.


Q: What are the main risks associated with stopping Tetravet before the recommended time?

Stopping the medicine before the entire recommended course is finished carries the risk of decreasing the treatment's effectiveness. This action increases the likelihood that remaining bacteria will develop resistance, potentially making future infections harder to treat.


Q: Does Tetravet affect blood pressure or heart rate according to official sources?

Regulatory documents do not state a change in blood pressure or heart rate during typical use. However, the safety information does note that serious cardiovascular effects (such as cardiovascular collapse) have been noted as a potential risk specifically associated with rare, severe allergic reactions (anaphylaxis).


Q: Is it true that Tetravet might interact with common supplements like multivitamins?

Yes, official information advises against taking the active ingredient with multivitamins that contain minerals like calcium, iron, magnesium, or zinc. These specific minerals can bind to the medicine in the stomach, which may reduce its absorption and overall effectiveness in the body.


Q: Is there any public research on Tetravet's use in children or teenagers?

Official regulatory documents acknowledge research in pediatric populations, which informs their warnings and contraindications. For instance, the drug is generally restricted for use in children under 8 years due to the documented risk of permanent tooth discoloration and inhibited bone growth.


Q: Does Tetravet have a known potential for causing sensitivity to the sun?

Yes, regulatory warnings state that photosensitivity has been observed in some individuals taking medicines in the tetracycline class. This reaction can appear as an exaggerated sunburn upon sun exposure, even in cases of only short-term exposure.


Q: What is the difference between Tetravet and other similar-sounding drugs?

Tetravet's active ingredient, Oxytetracycline, is part of the tetracycline group of antibiotics. This group contains several similar medicines, which mainly differ in their chemical structures and how long they remain active in the body, classifying them as short-, intermediate-, or long-acting agents.


Q: Is Tetravet considered a first-line treatment according to official guidelines?

The drug’s use is approved for specific bacterial infections. Whether it is classified as a first-line treatment is typically determined by the prescriber based on established medical protocols for the specific condition and regional factors.


Q: Are there any official statements about how Tetravet affects driving or operating machinery?

Official labeling for related medicines in the same class contains information that individuals should be aware of side effects related to the nervous system. Official product information suggests that nervous system side effects such as dizziness or light-headedness may influence the ability to operate vehicles or heavy machinery.


Q: Can Tetravet be safely stored outside of the refrigerator?

Official storage requirements describe the medicine as needing to be stored at or below 25 C (77 F) and must be protected from both light and freezing. This temperature range allows for standard storage conditions, provided the environment does not exceed the specified maximum of 25 C.


Q: Can Tetravet be used by people who have diabetes?

Regulatory warnings and contraindications do not specifically list diabetes as a restriction for use. The main contraindications focus on allergy, pregnancy, breastfeeding, young children, and severe kidney or liver impairment.


Q: Does Tetravet interact with hormonal birth control?

Authoritative public health guidance for this class of antibiotics suggests they generally do not affect the effectiveness of hormonal birth control (pills, patches, rings). The effectiveness of hormonal birth control is generally maintained when taken with this class of antibiotics.


Q: What happens if a person takes more Tetravet than prescribed?

Taking more of the medicine than prescribed can increase the risk of known side effects. Official information notes that signs of an excessive amount may include gastrointestinal upset, liver toxicity, or signs of elevated pressure around the brain, a condition known as intracranial hypertension.


Q: How does Tetravet interact with herbal remedies, based on official warnings?

Official regulatory reports do not offer a complete list of interactions with all herbal remedies. The need to disclose all herbal or dietary supplements is commonly emphasized in patient information, as some may affect the drug's absorption or potentially increase the risk of side effects like sun sensitivity.


Q: What is the current regulatory status of Tetravet (e.g., approved or undergoing review)?

The active ingredient, Oxytetracycline, is a widely used and long-established compound that has received regulatory approval from bodies like the FDA and EMA. Its use is governed by established labeling and indications approved by these authorities.


Q: Are there any specific lab tests required before or during treatment with Tetravet?

Official labeling states that for individuals undergoing long-term therapy with the active ingredient, periodic laboratory evaluation is generally recommended. This may include studies of the body’s organ systems, specifically the kidney (renal), liver (hepatic), and blood-forming (hematopoietic) systems.


Q: Does the drug literature mention any effect of Tetravet on sleep patterns?

Official regulatory documents do not commonly note effects specifically related to sleep patterns. However, side effects relating to the nervous system, such as general restlessness or trembling, have been reported in the literature.


Q: What are the official guidelines for disposal of unused Tetravet?

Official guidelines describe methods for disposal, which include community drug take-back programs or authorized mail-back envelopes when these are available. If drug take-back options are unavailable, regulatory guidance allows for the medicine to be mixed with an undesirable substance, placed in a sealed container, and disposed of in household trash, with instructions to avoid release into water sources.


Q: Is there a generic version of Tetravet available?

The active ingredient in Tetravet, Oxytetracycline, is a compound whose original patent has long expired. Therefore, while Tetravet may be a brand name, the active ingredient is commonly available in generic formulations.

How should Tetravet be stored and disposed of?

Storage and Disposal of Tetravet

Tetravet must be stored according to regulatory requirements to ensure potency and safety. The product should be stored at or below 25°C (77°F) and must be protected from light and freezing. Keep the container tightly closed and store it out of the sight and reach of children at all times.

Stability and Waste

Once the primary packaging of the injectable solution is opened, the product has a limited in-use shelf life, typically 28 days, after which unused portions must be discarded. Disposal must comply with local regulations and avoid release to the environment, particularly into water sources, as the product is labeled as toxic to aquatic organisms. Pressurized aerosol containers must not be punctured or burned.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tetravet found in:

A-Z Index: